FDA Inspection
Bausch & Lomb IncorporatedBausch & Lomb Incorporated – FDA Inspection, Mar 20, 2026
Record Details
This FDA Inspection record concerns Bausch & Lomb Incorporated, with an inspection on March 20, 2026, issued by the Florida District Office, covering human drugs.
View Company Profile
ID · 24144e7f-4a4d-4cf5-ba83-58245bc9802a
Inspection Facts
- Inspection number
- 1304548
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Bausch & Lomb Incorporated
10| Date | Classification | Office | Project area |
|---|---|---|---|
| August 25, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 30, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 10, 2018 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 26, 2017 | VAI | Center for Drug Evaluation and Research | New Drug Evaluation |
| February 25, 2016 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Bausch & Lomb Incorporated
- FDA Inspection 1218198 - 2023-08-25
- FDA Inspection 1082137 - 2019-01-30
- FDA Inspection 1061913 - 2018-08-10
- FDA Inspection 1015001 - 2017-05-26
- FDA Inspection 967714 - 2016-02-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.